Veru Inc. (VERU)
NASDAQ: VERU · IEX Real-Time Price · USD
1.270
+0.060 (4.96%)
At close: Apr 26, 2024, 4:00 PM
1.280
+0.010 (0.79%)
After-hours: Apr 26, 2024, 7:53 PM EDT

Veru Inc. Revenue

Veru Inc. had revenue of $15.93M in the twelve months ending December 31, 2023, down -42.55% year-over-year. Revenue in the quarter ending December 31, 2023 was $2.14M, a -14.64% decrease year-over-year. In the fiscal year ending September 30, 2023, Veru Inc. had annual revenue of $16.30M, a decrease of -58.59%.

Revenue (ttm)
$15.93M
Revenue Growth
-42.55%
P/S Ratio
11.67
Revenue / Employee
$84,285
Employees
189
Market Cap
185.90M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 202316.30M-23.06M-58.59%
Sep 30, 202239.35M-21.91M-35.76%
Sep 30, 202161.26M18.67M43.83%
Sep 30, 202042.59M10.79M33.92%
Sep 30, 201931.80M15.94M100.47%
Sep 30, 201815.86M2.21M16.18%
Sep 30, 201713.66M-8.47M-38.29%
Sep 30, 201622.13M-10.48M-32.13%
Sep 30, 201532.60M8.11M33.13%
Sep 30, 201424.49M-6.97M-22.15%
Sep 30, 201331.46M-3.58M-10.21%
Sep 30, 201235.03M16.47M88.71%
Sep 30, 201118.57M-3.66M-16.46%
Sep 30, 201022.22M-5.32M-19.32%
Sep 30, 200927.54M1.91M7.45%
Sep 30, 200825.63M6.31M32.68%
Sep 30, 200719.32M4.50M30.33%
Sep 30, 200614.82M3.66M32.82%
Sep 30, 200511.16M2.18M24.26%
Sep 30, 20048.98M-63.49K-0.70%
Sep 30, 20039.05M629.05K7.47%
Sep 30, 20028.42M1.70M25.32%
Sep 30, 20016.72M949.31K16.46%
Sep 30, 20005.77M1.05M22.30%
Sep 30, 19994.72M-735.92K-13.50%
Sep 30, 19985.45M2.53M86.92%
Sep 30, 19972.92M852.15K41.28%
Sep 30, 19962.06M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Akoya Biosciences 96.63M
Alimera Sciences 80.75M
OptimizeRx 71.52M
Codexis 70.14M
Semler Scientific 68.18M
908 Devices 50.23M
Cellectis 24.41M
Century Therapeutics 2.24M
Revenue Rankings